Get started
Author

Ilaria Vallini

Observed names: I. Vallini, Vallini, I
OpenAlex ID: A5021207124
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
2018 · Daniela Cardinale, Fabio Ciceri, et al. · European Journal of Cancer · 241
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study
2020 · Olga Nigro, Graziella Pinotti, et al. · European Journal of Cancer · 72
PDF
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
2022 · L. Cantini, G. Mentrasti, et al. · ESMO Open · 64
PDF
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019 · M.E. Cazzaniga, G. Pinotti, et al. · The Breast · 56
Biological effects of verbascoside and its anti-inflammatory activity on oral mucositis: a review of the literature
2019 · Olga Nigro, Alessandro Tuzi, et al. · Anti-Cancer Drugs · 41
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
2021 · M. E. Cazzaniga, I. Vallini, et al. · Breast Cancer Research and Treatment · 17
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration
2017 · Alessandro Tuzi, Elena Bolzacchini, et al. · Journal of Thoracic Disease · 16
PDF
Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Tract in Long-Standing Ulcerative Colitis: Report of a Case and Review of the Literature
2018 · Elena Bolzacchini, Claudio Chini, et al. · International Journal of Surgical Pathology · 12
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study
2019 · Elena Bolzacchini, Graziella Pinotti, et al. · Clinical Genitourinary Cancer · 7
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’
2022 · L. Cantini, G. Mentrasti, et al. · ESMO Open · 6
PDF
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
2023 · B. Trevisan, F. F. Pepe, et al. · Scientific Reports · 5
PDF
Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: A multicenter study
2019 · O. Nigro, A. Cortellini, et al. · Annals of Oncology · 5
Long-term therapy with Bevacizumab in a young patient affected by NF2. Stop or continue treatment? An update of a case report and review of the literature
2020 · Olga Nigro, Andrea Coppola, et al. · Anti-Cancer Drugs · 4
Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor–positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?
2020 · Olga Nigro, Cristina Marrazzo, et al. · Anti-Cancer Drugs · 4
Predictive variables of palbociclib dose reduction and its impact on survival outcomes: A retrospective bicentric study
2021 · Francesca Rita Ogliari, Francesca Caspani, et al. · The Breast Journal · 3
OA01.02 Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study
2021 · L. Cantini, G. Mentrasti, et al. · Journal of Thoracic Oncology · 2
PDF
Screening of distress in hospitalized patients: the experience of medical oncology department
2017 · G. Tinelli, C. Chini, et al. · Annals of Oncology · 1
PDF
Survey on prevalence and management of breakthrough cancer pain: a single center experience
2016 · E. Bolzacchini, A. Tuzi, et al. · Annals of Oncology · 1
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
2026 · Giulia Pasello, Claudia Proto, et al. · Frontiers in Oncology
PDF
Early male breast cancer: a single center experience
2017 · E. Grigioni, I. Marcon, et al. · Annals of Oncology
PDF
Expression and clinical-pathological correlations of the androgen receptor (AR) in a series of ER and PgR negative breast cancers undergoing surgery: our center experience
2017 · A. Ritorna, I. Marcon, et al. · Annals of Oncology
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study
2017 · M. Cazzaniga, L. Orlando, et al. · Annals of Oncology
Response rate by molecular subtypes and p53 expression in neoadjuvant therapy for breast cancer with TAC regimen: a single-centre experience
2017 · I. Marcon, I. Vallini, et al. · Annals of Oncology
Management of pT1mic,a,b pN0, ER- PgR- breast carcinoma: a single center experience
2017 · A. Ritorna, I. Marcon, et al. · The Breast
PDF
Multicenter retrospective study on new biomarkers predictive of response to sunitinib in metastatic renal cell carcinoma
2016 · G. Pinotti, E. Bolzacchini, et al. · Annals of Oncology
Works count: 35
Citation count: 573
H-index: 9
I10-index: 9
Year
Topic
Type